The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

BioAmber Inc

NYSE: BIOA
Last

(U.S.) $3.69

Today's change-0.02 -0.54%
Updated September 27 1:52 PM EDT. Delayed by at least 15 minutes.
 

BioAmber Inc

NYSE: BIOA
Last

(U.S.) $3.69

Today's change-0.02 -0.54%
Updated September 27 1:52 PM EDT. Delayed by at least 15 minutes.

BioAmber Inc crosses below 50-day moving average

BioAmber Inc is lower today, dropping (U.S.)$0.02 or 0.54% to (U.S.)$3.69 and crossing below its 50-day moving average. Over the last five days, shares have gained 3.65%, but are down 40.29% for the last year to date. Shares have underperformed the S&P 500 by 48.86% during the last year.

Key company metrics

  • Open(U.S.) $3.66
  • Previous close(U.S.) $3.71
  • High(U.S.) $3.76
  • Low(U.S.) $3.66
  • Bid / Ask(U.S.) $3.67 / (U.S.) $3.70
  • YTD % change-40.29%
  • Volume15,512
  • Average volume (10-day)39,715
  • Average volume (1-month)40,760
  • Average volume (3-month)38,171
  • 52-week range(U.S.) $2.86 to (U.S.) $8.92
  • Beta2.96
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.80
Updated September 27 1:52 PM EDT. Delayed by at least 15 minutes.

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue3110
Total other revenue--------
Total revenue3110
Gross profit-1-200
Total cost of revenue3310
Total operating expense10101010
Selling / general / administrative4443
Research & development2256
Depreciation / amortization1110
Interest expense (income), net operating--------
Unusual expense (income)0--00
Other operating expenses, total--------
Operating income-7-9-9-10
Interest income (expense), net non-operating-2-1-2-1
Gain (loss) on sale of assets--------
Other--------
Income before tax3-13-9-8
Income after tax3-13-9-8
Income tax, total0000
Net income5-11-8-7
Total adjustments to net income--------
Net income before extra. items5-11-8-7
Minority interest2211
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items5-11-8-7
Inc. avail. to common incl. extra. items5-11-8-7
Diluted net income5-11-8-7
Dilution adjustment0------
Diluted weighted average shares30282626
Diluted EPS excluding extraordinary itemsvalue per share0.16-0.39-0.30-0.27
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share0.16-0.39-0.30-0.27